i-Visc · i-Visc VISCOELASTIC SOLUTION FOR INTRAOCULAR USE based on SODIUM HYALURONATE...
Transcript of i-Visc · i-Visc VISCOELASTIC SOLUTION FOR INTRAOCULAR USE based on SODIUM HYALURONATE...
i-Medical Ophthalmic International Heidelberg GmbHMarkircher Straße 7 • 68229 Mannheim • Germany • www.imedical.de
i-ViscVISCOELASTIC SOLUTION FOR INTRAOCULAR USE based on SODIUM HYALURONATE
Specification
Sodium hyaluronate
Molecular weight [mio. Daltons]
Viscosity* [mPas]
Osmolality [mOsm/kg]
Storage
pH
Volume [ml]
Shelf life [months]
* after steam sterilization
1.0 %
1.1 - 1.5
approx. 20 000
270 - 400
2° - 25° C
6.8 - 7.4
1.0
42
1.4 %
1.1 - 2.0
approx. 30 000
270 - 400
2° - 25° C
6.8 - 7.4
1.0
42
1.6 %
1.2 - 2.0
approx. 60 000
270 - 400
2° - 25° C
6.8 - 7.4
1.0
42
1.8 %
1.2 - 2.0
approx. 100 000
270 - 400
2° - 25° C
6.8 - 7.4
1.0
42
3.0 %
1.0 - 1.8
approx. 300 000
270 - 400
2° - 25° C
6.8 - 7.4
1.0
42
Composition [1ml]
Sodium hyaluronate
Sodium chloride
Disodium hydrogenphosphate 2 H2O
Sodium dihydrogenphosphate 2 H2O
Water for injection
10.000 mg
8.500 mg
0.563 mg
0.045 mg
q.s.
14.000 mg
8.500 mg
0.563 mg
0.045 mg
q.s.
16.000 mg
8.500 mg
0.563 mg
0.045 mg
q.s.
18.000 mg
8.500 mg
0.563 mg
0.045 mg
q.s.
30.000 mg
6.500 mg
0.563 mg
0.045 mg
q.s.
i-Visc 1.0
i-Visc 1.0 i-Visc 1.4
i-Visc 1.4 i-Visc 1.6
i-Visc 1.6
i-Visc 1.8
i-Visc 1.8
i-Visc 3.0
i-Visc 3.0
• Free of conservation substances• Isotonic solution• Good maintenance of the anterior chamber and the capsular bag • No preservatives• Steam sterilized• No in�ammable or immunogene reaction• Easy to inject• Easy to remove• CE certi�ed
0481